Benefits
Antioxidant Properties
Green tea supplements are rich in catechins, particularly EGCG, which neutralize free radicals, reducing oxidative stress and potentially protecting against cellular damage linked to aging and chronic diseases.
Weight Management Support
Catechins and caffeine in green tea may enhance metabolism and fat oxidation, modestly aiding weight loss or maintenance when combined with a healthy diet and exercise. Studies show small but significant effects on body weight and fat reduction.
Cardiovascular Health
Green tea supplements may improve heart health by reducing LDL ("bad") cholesterol levels, lowering blood pressure, and improving blood vessel function, potentially decreasing the risk of heart disease.
Cognitive Function
Compounds like EGCG and L-theanine may support brain health, improving focus, memory, and mood while potentially reducing the risk of neurodegenerative diseases like Alzheimer’s, though more research is needed.
Anti-Inflammatory and Immune Support
Polyphenols in green tea have anti-inflammatory properties and may modulate immune responses, potentially aiding in overall immune health and reducing inflammation-related conditions.
Mechanism of action
Antioxidant Activity
Catechins, especially EGCG, act as potent antioxidants by scavenging free radicals and reducing oxidative stress. They inhibit reactive oxygen species (ROS) and upregulate antioxidant enzymes, protecting cells from damage linked to aging and chronic diseases.
Metabolic Enhancement for Weight Management
EGCG and caffeine stimulate thermogenesis and fat oxidation by inhibiting the enzyme catechol-O-methyltransferase (COMT), which prolongs the activity of norepinephrine, a hormone that boosts metabolism. This increases energy expenditure and fat breakdown, supporting weight loss.
Cardiovascular Benefits
Catechins improve lipid metabolism by reducing LDL cholesterol oxidation and inhibiting cholesterol absorption in the gut. They also enhance endothelial function by increasing nitric oxide production, which promotes vasodilation and lowers blood pressure, reducing cardiovascular risk.
Neuroprotective Effects
EGCG crosses the blood-brain barrier and may protect neurons by reducing oxidative stress and inflammation. L-theanine promotes alpha brain wave activity, enhancing relaxation and focus, while caffeine improves alertness by blocking adenosine receptors.
Anti-Inflammatory and Immune Modulation
Catechins inhibit pro-inflammatory pathways (e.g., NF-κB) and modulate immune cell activity, reducing inflammation and potentially enhancing immune responses. This may help manage inflammatory conditions and support overall immunity.
Clinical trials
Randomized, placebo-controlled, double-blind, parallel-group trial (NCT03628937) in Japan involving 60 healthy adults receiving combined green tea catechins + α-glucosyl hesperidin (G-Hsp) vs placebo for 12 weeks. (2021 Japanese trial)
60 healthy adults. 12-week intervention.
Combined intervention modestly reduced body fat and BMI vs placebo. Note: multi-ingredient trial — green tea-attributable effects cannot be cleanly isolated. Effects align with broader green tea catechin literature for modest weight management benefits.
Pooled analysis of 16 clinical trials (17 arms, 760 participants) evaluating green tea effects on oxidative stress markers (TAC, MDA, GPX, SOD). (2021 pooled analysis)
Pooled across 16 clinical trials, 760 participants.
Green tea significantly increased Total Antioxidant Capacity (WMD +0.20 mmol/L) and reduced malondialdehyde (lipid peroxidation marker) vs placebo. Effects more pronounced in longer interventions. Confirms catechin antioxidant mechanism translates to in vivo biomarker improvements.
Pooled analysis of 55 clinical trials (63 effect sizes) examining green tea effects on cardiovascular risk factors including lipids, blood pressure, glucose. (2023 pooled analysis)
Pooled across 55 clinical trials.
Green tea significantly reduced total cholesterol (~7 mg/dL), LDL (~4 mg/dL), systolic BP (~1-2 mmHg), and fasting glucose. Effects modest but consistent. Mechanism via EGCG-mediated effects on lipid metabolism and endothelial function. Population-level effects more meaningful than individual-level intervention.
Randomized controlled trial in 62 girls with obesity aged 6-10 receiving 400 mg/day decaffeinated green tea polyphenols vs placebo. Outcomes: anthropometrics, safety, liver function. (2024 Chinese trial)
62 obese girls aged 6-10.
Modest effects on anthropometric measures vs placebo; NO adverse effects on liver function or other safety markers in pediatric population. Important pediatric safety data given concerns about high-dose green tea catechin hepatotoxicity in adults.
Clinical trial in 45 women with PCOS receiving green tea tablets vs placebo for 12 weeks. Outcomes: anthropometric indices, inflammatory markers, hormonal markers. (2017)
45 women with PCOS. 12-week intervention.
Modest improvements in inflammatory markers and weight measures vs placebo. PCOS management primarily relies on lifestyle modification and metformin; green tea is at most adjunctive.
Pooled analysis of clinical trials (search through) evaluating green tea supplementation for NAFLD. Outcomes: liver enzymes, lipid profile, weight. (2018)
Pooled across NAFLD clinical trials.
Green tea modestly reduced ALT, AST, total cholesterol, and body weight in NAFLD patients vs placebo. Critical hepatotoxicity caution: this paradoxical relationship — green tea has been shown to modestly improve NAFLD markers, but high-dose green tea extracts (>800 mg EGCG/day) have been associated with rare cases of acute hepatotoxicity, sometimes severe. The 2018 EFSA report classified high-dose green tea catechins (≥800 mg EGCG/day) as potentially associated with hepatotoxicity. Most clinical trials use lower doses (<400 mg EGCG/day) which are safer.